三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
三大ATTR-CM核心品牌(Tafa/Attruby/Vutrisiran)及艾拉伦制药Patisiran过往季度销售
三大ATTR-CM核心品牌(Tafa/Attruby/Vutrisiran)及艾拉伦制药Patisiran过往季度销售
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:187KB
图片尺寸:2317*908
同报告图片
/
4
PHxiZWdpbl9vZl9ib3h8Pnwg5a2j5bqmICAgfCBQRkUgVGFmYW1pZGlzIChtbiBVU0QpIHwgQUxOWSBWdXRyaXNpcmFuIChtbiBVU0QpIHwgQUxOWSBQYXRpc2lyYW4gKG1uIFVTRCkgfCBCQklPIEF0dHJ1YnkgKG1uIFVTRCkgfAp8LS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMVEyMSAgIHwgNTAwICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgIHwKfCAyUTIxICAgfCA1NTAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgfAp8IDNRMjEgICB8IDYwMCAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICB8CnwgNFEyMSAgIHwgNjUwICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgIHwKfCAxUTIyICAgfCA3MDAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgfAp8IDJRMjIgICB8IDc1MCAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICB8CnwgM1EyMiAgIHwgODAwICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgIHwKfCA0UTIyICAgfCA4NTAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgfAp8IDFRMjMgICB8IDkwMCAgICAgICAgICAgICAgICAgICAgIHwgNTAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICB8CnwgMlEyMyAgIHwgOTUwICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgIHwKfCAzUTIzICAgfCAxMDAwICAgICAgICAgICAgICAgICAgICB8IDE1MCAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgfAp8IDRRMjMgICB8IDExMDAgICAgICAgICAgICAgICAgICAgIHwgMjAwICAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICB8CnwgMVEyNCAgIHwgMTIwMCAgICAgICAgICAgICAgICAgICAgfCAyNTAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgIHwKfCAyUTI0ICAgfCAxMzAwICAgICAgICAgICAgICAgICAgICB8IDMwMCAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICAgfAp8IDNRMjQgICB8IDE0MDAgICAgICAgICAgICAgICAgICAgIHwgMzUwICAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICB8CnwgNFEyNCAgIHwgMTUwMCAgICAgICAgICAgICAgICAgICAgfCA0MDAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgIHwKfCAxUTI1ICAgfCAxNjAwICAgICAgICAgICAgICAgICAgICB8IDQ1MCAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfCA1MCAgICAgICAgICAgICAgICAgICAgfAp8IDJRMjUgICB8IDE3MDAgICAgICAgICAgICAgICAgICAgIHwgNTAwICAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICAgICB8IDEwMCAgICAgICAgICAgICAgICAgICB8CnwgM1EyNSAgIHwgMTgwMCAgICAgICAgICAgICAgICAgICAgfCA1NTAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwICAgICAgICAgICAgICAgICAgICAgIHwgMTUwICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muaLm+WVhuivgeWIuO+8iOmmmea4r++8iTx8ZW5kX29mX2JveHw+
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
所属报告:
艾拉伦制药(ALNY.US)-美股公司研究报告:管理层交流反馈:Amvuttra全球商业化强劲推进及主要临床项目进展-251127(13页).pdf
打包全文图表
相关数据
图表22中国艾司奥美拉唑镁肠溶片竞争格局
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
收藏
竞争格局
2026-03-16
原图定位
查看详情
艾拉伦制药产品销售(不含合作及特许权收入)
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
收藏
行业数据
2025-12-05
原图定位
查看详情
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势
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
收藏
行业数据
2025-12-05
原图定位
查看详情
针对TTR疾病(ATTR-PN及ATTR-CM)的疗法当前FDA批准新药状态
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
收藏
行业数据
2025-12-05
原图定位
查看详情
2024年尼拉帕利、艾加莫德销售占比较大
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
收藏
行业数据
2025-06-12
原图定位
查看详情
艾拉莫德片全国医院销售情况
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
收藏
行业数据
2025-02-14
原图定位
查看详情
艾拉司群销售额预测(亿元)
fOW5tOS7vSB86ZSA5ZSu6aKd77yI5Lq/5YWD77yJIHzkubPohbrnmYwgfAp8LS0tfC0tLXwtLS18CnwyMDI2RXwyLjU3fDIuNTcKfDIwMjdFfDYuNDl8Ni40OQp8MjAyOEV8MTMuNzZ8MTMuNzYKfDIwMjlFfDE2LjU1fDE2LjU1CnwyMDMwRXwxOC43MnwxOC43Mgp8MjAzMUV8MjAuMjZ8MjAuMjYKCui1hOaWmeadpea6kO+8muilv+WNl+ivgeWIuOaVtOeQhg==
收藏
其它
2024-02-20
原图定位
查看详情
注射用艾司奥美拉唑钠样本医院市场格局(亿
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
收藏
行业数据
2023-11-07
原图定位
查看详情
NTLA-2001临床I期针对心肌疾病(ATTR-CM)的设计
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
收藏
行业数据
2023-07-05
原图定位
查看详情
ATTR-CM临床I期NTLA-2001降低血清TTR的有效性数据
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
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2001临床I期针对ATTR引起的心肌疾病(ATTRv-CM)的安全性
fCBQYXJhbWV0ZXIgfCBOWUhBIENsYXNzIElJL0lJSSAwLjcgbWcva2cgbiA9IDMgfCBOWUhBIENsYXNzIElJSSAwLjcgbWcva2cgbiA9IDYgfCBOWUhBIENsYXNzIElJL0lJSSAxLjAgbWcva2cgbiA9IDMgfCBBbGwgUGF0aWVudHMgbiA9IDEyIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8IFBhdGllbnRzIHdpdGggYXQgbGVhc3Qgb25lIFRFQUUgfCAyIHwgMyB8IDEgfCA2IHwKfCBJbmZ1c2lvbi1yZWxhdGVkIHJlYWN0aW9uIHwgLSB8IC0gfCAxIHwgMSB8CnwgQ09WSUQtMTkgfCAtIHwgMSB8IC0gfCAyIHwKCui1hOaWmeadpea6kO+8mkludGVsbGlhIFRoZXJhcGV1dGljc++8jOS4remTtuivgeWIuA==
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2001临床I期针对遗传性ATTR引起的多发性神经疾病(ATTRv-PN)的安全性
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
收藏
行业数据
2023-07-05
原图定位
查看详情
艾拉莫德销售额测算
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
收藏
行业数据
2023-04-18
原图定位
查看详情
艾拉莫德销售额持续攀升
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
收藏
行业数据
2023-04-18
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
如关键图表中的图 2所示,我们剔除 ATTR-PN适应症的大致销售,得到 ATTR-PM的估算值,并与辉瑞 Tafamidis 及BridgeBio Attruby 对比,根据上市首几个季度销售数据,Alnylam 在完整两个季度后实现更高销售额。与此同时,Tafamidis 在 2025 年二、三季度呈现趋平态势(见下图)。
行业数据
原图定位
当前图表所属:
艾拉伦制药(ALNY.US)-美股公司研究报告:管理层交流反馈:Amvuttra全球商业化强劲推进及主要临床项目进展-251127(13页).pdf
NucresiranATTR-CMTRITON-CM三期设计
艾拉伦制药对Vutrisiran未来支付比例指引
三大ATTR-CM核心品牌(Tafa/Attruby/Vutrisiran)及艾拉伦制药Patisiran过往季度销售
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》